AACR logo

More articles from Therapeutic Agents: Other: Poster Presentations - Proffered Abstracts

Abstract C172: A synthetic glycolipid induces macrophage-mediated apoptosis of cancer cells via nitric oxide-dependent downregulation of thoc1 gene.
Yong-Shiang Lin, Chao-Hsiung Lin, Chun-Cheng Lin, Shu-Ling Fu

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) C172; DOI: 10.1158/1535-7163.TARG-11-C172
Abstract C173: APE1/Ref-1-STAT3 dual-targeting synergize to effectively inhibit pancreatic cancer cell survival.
Melissa L. Fishel, Yanlin Jiang, Meihua Luo, April M. Reed, Ying He, Angelo M. Cardoso, Mark R. Kelley

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) C173; DOI: 10.1158/1535-7163.TARG-11-C173
Abstract C171: TriplatinNC, a nucleolar-targeting platinum agent. Heparan sulfate-mediated cell entry, localization, and apoptosis.
Erica Peterson, Heveline Silva, Vijay Menon, Brad Benedetti, Ralph Kipping, Nicholas Farrell

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) C171; DOI: 10.1158/1535-7163.TARG-11-C171
Abstract B224: Structure-based drug design of signal transducers and activator of transcription 5 inhibitors.
Abbarna A. Cumaraswamy, Patrick T. Gunning

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) B224; DOI: 10.1158/1535-7163.TARG-11-B224
Abstract B223: NKP-1339 synergistic activity in both in vitro and in vivo preclinical models highlights the therapeutic opportunity for NKP-1339 combination trials with a broad range of antitumor agents.
Rebecca Baerga, Jenel Cobb, Angela Ogden, Hooshmand Sheshbaradaran

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) B223; DOI: 10.1158/1535-7163.TARG-11-B223
Abstract B213: Isolation of muscle fatigue substance(s) with antitumor activities.
Ruben M. Munoz, Haiyong Han, Daniel D. Von Hoff, Stanley Hoffman

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) B213; DOI: 10.1158/1535-7163.TARG-11-B213
Abstract B214: Antagonizing CBP/beta-catenin signaling-enhanced radiation sensitivity and altered epithelial-mesenchymal transition markers in head and neck squamous cell carcinoma.
Vicky N. Yamamoto, Michael Kahn, Vijay K. Kalra, Uttam K. Sinha

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) B214; DOI: 10.1158/1535-7163.TARG-11-B214
Abstract B216: A soil-to-seeds anticancer strategy: Targeting stroma to kill cancer cells.
Yicheng Ni

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) B216; DOI: 10.1158/1535-7163.TARG-11-B216
Abstract B218: CBP/catenin antagonism inhibits self-renewal of acute lymphoblastic leukemia.
Eun Ji Gang, Eugene Park, Priyamvada Jayaprakash, Sandra Huantes, Yao-Te Hsieh, Dylan Hanami, Srividya Swaminathan, Lars Klemm, Markus Mschen, Michael McMillan, Cu Nguyen, Yi Zhao, Michael Kahn, Yong-Mi Kim

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) B218; DOI: 10.1158/1535-7163.TARG-11-B218
Abstract B220: Artificially inducing protein-membrane anchorage: Introducing a new therapeutic modality.
Miriam Avadisian, Steven Fletcher, Baoxu Liu, Wei Zhao, Peibin Yue, James Turkson, Claudiu Gradinaru, Patrick Gunning

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) B220; DOI: 10.1158/1535-7163.TARG-11-B220

Main menu

User menu

Search

More articles from Therapeutic Agents: Other: Poster Presentations - Proffered Abstracts

Pages

Articles

Info for

About MCT